CIK 0000818033 · Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 942875566
- Phone
- 8582514400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-13 | Szekeres David Leslie EVP, Chief Operating Officer | Option exercise · Restricted Stock Units | −1,250 | 16,250 | ||
| 2021-07-13 | Quart Barry D Chief Executive Officer | Option exercise | +3,645 | 100,366 | ||
| 2021-07-13 | Quart Barry D Chief Executive Officer | Shares withheld for taxes | −963 | $13.48 | $13K | 99,403 |
| 2021-07-13 | Quart Barry D Chief Executive Officer | Option exercise · Restricted Stock Units | −3,645 | 47,396 | ||
| 2021-07-13 | POYHONEN JOHN President & CCO | Option exercise | +1,250 | 22,635 | ||
| 2021-07-13 | POYHONEN JOHN President & CCO | Shares withheld for taxes | −433 | $13.48 | $6K | 22,202 |
| 2021-07-13 | POYHONEN JOHN President & CCO | Option exercise · Restricted Stock Units | −1,250 | 16,250 | ||
| 2021-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise | +552 | 14,027 | ||
| 2021-07-13 | Peraza Lisa VP, Chief Accounting Officer | Shares withheld for taxes | −191 | $13.48 | $3K | 13,836 |
| 2021-07-13 | Peraza Lisa VP, Chief Accounting Officer | Option exercise · Restricted Stock Units | −552 | 7,177 | ||
| 2021-07-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise | +1,250 | 2,884 | ||
| 2021-07-13 | MANHARD KIMBERLY EVP, Drug Development | Shares withheld for taxes | −433 | $13.48 | $6K | 2,451 |
| 2021-07-13 | MANHARD KIMBERLY EVP, Drug Development | Option exercise · Restricted Stock Units | −1,250 | 16,250 | ||
| 2021-06-21 | Christian Waage Director | Sale | −300 | $15.20 | $5K | 3,800 |
| 2021-06-21 | Johnson Craig A Director | Sale | −250 | $15.20 | $4K | 3,340 |
| 2021-05-03 | MANHARD KIMBERLY EVP, Drug Development | Sale | −1,529 | $17.66 | $27K | 1,634 |
| 2021-04-30 | Szekeres David Leslie EVP, Chief Operating Officer | Other acquisition | +1,530 | $13.90 | $21K | 2,347 |
| 2021-04-30 | Quart Barry D Chief Executive Officer | Other acquisition | +1,529 | $13.90 | $21K | 96,721 |
| 2021-04-30 | POYHONEN JOHN President & CCO | Other acquisition | +971 | $13.90 | $13K | 21,385 |
| 2021-04-30 | Peraza Lisa VP, Chief Accounting Officer | Other acquisition | +1,530 | $13.90 | $21K | 13,475 |
Page 26 of 28 · 557 trades